See All Slides - tctmd.com

Slides

Presentation TCT 2014

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Presenter: Valentin Fuster, Pieter C. Smits

September 13, 2014

Presentation TCT 2014

Introduction: A Historic Perspective on Antegrade CTO PCI

Presenter: Minh Vo, Gerald S. Werner, R. Michael Wyman

September 13, 2014

Presentation TCT 2014

Tricuspid Regurgitation: Natural History and Surgical Indications and Outcomes

Presenter: Alec S. Vahanian, James S. Gammie

September 13, 2014

Presentation TCT 2014

Opening CTOs Cant Make Things Worse or Can It? The Spectrum of CTO- and PCI-Related Complications

Presenter: Liliana R. Grinfeld, Robert W. Yeh, Sudhir Rathore

September 13, 2014

Presentation TCT 2014

Preprocedure Groundwork: Imaging the LAA and Device Selection

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz

September 13, 2014

Presentation TCT 2014

Antithrombin Alternatives: Pros and Cons

Presenter: Harold L. Dauerman

September 13, 2014

Presentation TCT 2014

What is the SCAI Cath Lab Leadership Boot Camp?

Presenter: Peter L. Duffy, Sunil V. Rao, Charles E. Chambers

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

Presentation TCT 2014

CT Imaging Protocols and Techniques for Annular Measurement

Presenter: Gregory P. Fontana, Jean-Claude Laborde, Jonathon A. Leipsic

September 13, 2014

Presentation TCT 2014

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Robert J. Applegate, Ronald Caputo, Steven J. Yakubov

September 13, 2014

Advertisement

Slides

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Introduction: A Historic Perspective on Antegrade CTO PCI

Tricuspid Regurgitation: Natural History and Surgical Indications and Outcomes

Opening CTOs Cant Make Things Worse or Can It? The Spectrum of CTO- and PCI-Related Complications

Preprocedure Groundwork: Imaging the LAA and Device Selection

Antithrombin Alternatives: Pros and Cons

What is the SCAI Cath Lab Leadership Boot Camp?

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

CT Imaging Protocols and Techniques for Annular Measurement

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content